- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 1000 mg metformin
Total 13539 results
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
International Bio serviceNot yet recruiting
-
Beni-Suef UniversityRecruiting
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus(T2DM)China
-
Handok Inc.Completed
-
Gmax Biopharm LLC.RecruitingPulmonary Arterial HypertensionUnited States, China
-
Damanhour UniversityTanta UniversityCompletedCoronary Artery Disease | Diabetes Mellitus, Type 2Egypt
-
Solvay PharmaceuticalsCompletedDiabetes Mellitus, Type 2 | DyslipidemiaFrance
-
Mayo ClinicRecruiting
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Global Alliance for TB Drug DevelopmentCompletedFood Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-003)TuberculosisUnited States
-
Spero TherapeuticsRecruitingNontuberculous Mycobacterial Pulmonary Disease (NTM-PD)United States
-
gicare Pharma Inc.Algorithme Pharma IncCompletedPain | Cancer | Colonic DiseaseCanada
-
Janssen Research & Development, LLCCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Mid Atlantic RetinaCompletedDiabetic Retinopathy | Retinal Detachment | Vitrectomy | Proliferative VitreoretinopathyUnited States
-
AstraZenecaCompletedBioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and MetforminUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
Pharmacosmos A/SCompleted
-
Natureceuticals Sdn BhdCompleted
-
AngiogenixUnknownSickle Cell DiseaseUnited States
-
Canadian Heart Research CentreGlaxoSmithKlineCompletedType 2 Diabetes MellitusCanada
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
GlaxoSmithKlineCompleted
-
Oman Ministry of HealthNot yet recruitingObesity | Weight Loss | Effect of Drug | Dapagliflozin Adverse Reaction
-
German University in CairoRecruiting
-
GL Pharm Tech CorporationCompletedHealthyKorea, Republic of
-
Chang Gung Memorial HospitalActive, not recruitingDepressive Disorder, Treatment-ResistantTaiwan
-
Innate PharmaCompletedInflammation | Rheumatoid ArthritisGermany
-
GL Pharm Tech CorporationCompletedHealthyKorea, Republic of
-
ModernaTX, Inc.CompletedSeasonal InfluenzaUnited States
-
Oslo University HospitalRecruitingCeliac Disease | Food IntoleranceNorway, Germany
-
Tanta UniversityNot yet recruitingBreast Cancer Female
-
Ministry of Health, TurkeyIstanbul University; Ankara Training and Research Hospital; Prof. Dr. Cemil Tascıoglu... and other collaboratorsActive, not recruitingCOVID-19 | Sars-CoV2Turkey
-
Boehringer IngelheimEli Lilly and CompanyCompletedHyperglycemia | Diabetes Mellitus, Type 2United States, Brazil, Canada, Czech Republic, Egypt, France, Germany, Guatemala, Korea, Republic of, Lebanon, Malaysia, Mexico, Peru, Philippines, Russian Federation, Serbia, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
SFJ Pharmaceuticals, Inc.SFJ Pharmaceuticals, Inc.Terminated
-
Spanish Oncology Genito-Urinary GroupRoche Pharma AGCompletedLocally Advanced or Metastatic Urothelial CarcinomaSpain
-
Khyber Medical University PeshawarCompleted
-
Medicines for Malaria VentureRichmond Pharmacology LimitedCompleted
-
Bumi HermanCompleted
-
Staidson (Beijing) Biopharmaceuticals Co., LtdRecruiting
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, PulmonaryUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Quark PharmaceuticalsTerminatedNon Arteritic Anterior Ischemic Optic NeuropathyUnited States, Australia, Germany, China, India, Italy, Singapore, Israel
-
Woman'sAstraZenecaCompletedDapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women (DAPA-GDM)Diabetes Prevention in Women After GDM Who Are at High-riskUnited States
-
Maastricht University Medical CenterCompleted